FOR IMMEDIATE RELEASE AnPac Bio Files Coronavirus Detection Patent and Initiates Related Research Project San Jose, CA, February 27, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that […]
San Jose, CA, February 6, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has gained two new insurance customers in China for its cancer screening and detection […]
FOR IMMEDIATE RELEASE AnPac Bio Announces Pricing of Initial Public Offering San Jose, CA, January 30, 2020 – AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio” or the “Company”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, today announced that it has priced its […]
ANPAC BIO APPOINTS NOBEL PRIZE WINNER DR. MICHAEL LEVITT AS CHIEF CONSULTANT TO LEAD ANPAC’S PIONEERING EFFORTS IN CANCER SCREENING San Jose, CA – December 11, 2019 – Anpac Bio-Medical Science Co., Ltd. (“Anpac Bio” or the “Company”) announced today the appointment of Professor Michael Levitt of Stanford University to be the Chief Consultant of […]
Anpac-Bio-Abstract-Evaluation-of-a-Multi-Level-Multi-Parameter-Detection-Method-for-Digestive-System-Cancer-Diagnosis
Anpac-Bio-Abstract-Investigations-of-a-New-Diagnostics-Technology-for-Hepatocellular-Carcinoma-Screening
Anpac-Bio-Abstract-Investigations-of-an-Improved-Esophageal-Cancer-Diagnostics-Approach
Anpac-Bio-Abstract-Investigations-of-Breast-Cancer-Screening-Using-a-Novel-In-Vitro-Diagnostics-Technology
Anpac-Bio-Abstract-Investigations-on-Non-Small-Cell-Lung-Cancer-Screening